| Similar Articles |
 |
The Motley Fool April 7, 2011 Brandon Glenn |
"Generic Wave" to Drive Cardinal Health's Profitability in Coming Years The generic wave could mean big money for Cardinal and top competitors.  |
Chemistry World June 12, 2007 Simon Hadlington |
A New Way to Look at the Brain Researchers have for the first time scanned the human brain with positron emission tomography and magnetic resonance imaging simultaneously. The work introduces the possibility of obtaining both highly specific functional data together with anatomical information in a single scan.  |
BusinessWeek November 24, 2003 Roger O. Crockett |
Cardinal Health, Heal Thyself CEO Walter aims to revive growth, selling high-tech gear and expanding overseas.  |
The Motley Fool August 24, 2011 Brandon Glenn |
Cardinal Health Sees Opportunity (but Faces Challenges) in Specialty Drugs Is Cardinal up for the challenge?  |
Chemistry World October 14, 2008 Manisha Lalloo |
Radiopharmaceutical shortage raises long-term supply questions A temporary European shortage of radionuclides, caused by the closure of several nuclear reactors, has highlighted potential long-term problems with the supply of radioactive isotopes for medical imaging.  |
The Motley Fool November 8, 2011 Brandon Glenn |
Cardinal Health Looks to Build China Business, but Has Long Way to Go For pharmaceuticals distributor Cardinal Health, China represents a world of opportunity.  |
The Motley Fool January 30, 2006 Brian Gorman |
Cardinal Inches Higher The distribution is looking healthier, but Cardinal Health still has work to do. Investors, take note.  |
Managed Care July 2006 Lola Butcher |
Oncologic PET Study Seeks Basis for Coverage Decisions The launch of a new registry that will significantly expand Medicare's coverage of positron emission tomography may bring new clarity on appropriate uses for this technology -- and even more pressure on commercial health plans to cover the high-cost scans.  |
The Motley Fool September 30, 2008 Brian Orelli |
Cardinal Health Clips Its Wings Does it make sense for the drug wholesaler to spin off its medical equipment business?  |
The Motley Fool October 28, 2004 Brian Gorman |
Cardinal's Good News: No News The drug wholesaler took a major step toward rehabilitating itself with the release of its 10-K.  |
The Motley Fool June 28, 2005 Brian Gorman |
Cardinal Changes Course The health care company's warning is a disappointment, but the firm's new focus on returning cash to shareholders is far from bad news.  |
The Motley Fool June 13, 2006 Ryan Fuhrmann |
Cardinal Looks to Deliver Cardinal Health has been through a tumultuous couple of years but appears to have weathered company-specific and industry storms. If the drug distributor can meet its long-term goals, then its stock should represent a long-term solid investment.  |
The Motley Fool January 18, 2005 Brian Gorman |
Cardinal Doesn't Get Ruffled The drug distributor's potential loss of Japanese pharmaceutical Eisai will hurt in the short term, but fortunately for investors Cardinal Health continues to plan wisely.  |
The Motley Fool September 2, 2009 Brian Orelli |
Should You Buy This Spinoff? Cardinal Health kicks its baby out of the nest.  |
The Motley Fool December 10, 2004 Brian Gorman |
Cardinal Picks a Lilly Cardinal Health's deal with Lilly suggests the new fee-for-service model is gaining traction.  |
The Motley Fool May 20, 2004 Tom Taulli |
Cardinal Rules of M&A Cardinal Health is upbeat on its latest acquisition, but needs bigger deals to push growth.  |
IEEE Spectrum March 2012 Prachi Patel |
Should You Still Choose Nuclear Engineering as a Career? Despite Fukushima, nuclear engineering still promises a stable career  |
The Motley Fool January 26, 2007 Billy Fisher |
A Clean Bill of Health at Cardinal Good results and a key divestiture have this health care company rolling. Investors, take note.  |
The Motley Fool May 2, 2008 Steven Renaldi |
Cardinal Health Gets Its Nest in Order Share price rises as investors hope the company is beginning to put some of its troubles behind it.  |
Chemistry World March 3, 2015 Phillip Broadwith |
J&J to sell cardiac devices to wholesaler Cardinal Johnson & Johnson has agreed to sell its cardiovascular surgical devices subsidiary, Cordis, to wholesale supplier Cardinal Health.  |
Popular Mechanics December 29, 2008 Jeremy Jacquot |
3 Projects We Hope to See From the DOE's Next Nuclear Research Facility Studying rare nuclear isotopes with unstable, short-lived nuclei has plenty of practical and commendable applications in medicine, national security, and cosmology.  |
The Motley Fool October 6, 2008 Brian Orelli |
Cardinal Atones for Its Sins The drugmaker gets its licenses to distribute controlled substances reinstated.  |
The Motley Fool August 3, 2006 Ryan Fuhrmann |
Cardinal Distributes the Goods The drug wholesaler and distributor has to regain investor confidence and rebuild a track record in a changed industry. So far, so good for 2006. Let's see if any further information can be found once Cardinal submits its 10-K filing to the SEC.  |
The Motley Fool July 28, 2004 Brian Gorman |
Cardinal Watching Cardinal Health continues to be pummeled, but wait patiently, because a buying opportunity could emerge.  |
The Motley Fool March 23, 2011 Jordan DiPietro |
Should You Buy and Hold Cardinal Health? Does this company have the traits of a good retirement stock?  |
The Motley Fool April 25, 2011 Travis Hoium |
Throwing In the Towel on Nuclear NRG's writedown of a nuclear development may signal the end of hope for nuclear developments.  |
IEEE Spectrum May 2011 Prachi Patel |
The Aging Nuclear Workforce A third of all workers in U.S. nuclear plants will be eligible to retire in the next five years.  |
The Motley Fool May 2, 2011 Suman Chatterjee |
Why the Nuclear Power Industry Looks Shaky If your portfolio contains any nuclear related stock, you should rethink.  |
The Motley Fool November 7, 2007 Billy Fisher |
Cardinal Has Its Wings Clipped Despite a healthy year-over-year pop of 15% in EPS from operations, much of the focus in the first-quarter was shifted to a weak performance by Cardinal's pharmaceutical services segment.  |
The Motley Fool September 28, 2010 |
Go Nuclear in Your Portfolio America is going nuclear, folks. How can you profit from the current nuclear trend?  |
The Motley Fool December 9, 2011 Travis Hoium |
3 Reasons to Avoid Nuclear Power Safety, costs, and energy trends make nuclear a poor investment right now.  |
BusinessWeek September 17, 2007 Christine Todd Whitman |
The Case For Nuclear Power Nuclear power is a chance to meet our future energy needs while preserving the Earth's climate.  |